In the fast‑moving world of clinical research, Contract Research Organisations (CROs) need digital tools that can keep pace with complexity, compliance requirements and expanding client expectations. Increasingly, CROs choosing Xolomon as their platform of choice for powering digital trials reflects a broader shift toward flexible, scalable and integrated solutions.
But what exactly makes Xolomon stand out for CROs worldwide?
A platform built for real‑world research needs
At its core, Xolomon offers a suite of digital tools designed for the life of a clinical study, from data capture and management to trial administration and patient engagement. All solutions are cloud‑based SaaS, requiring only an internet browser to access. This means CRO teams can focus less on deployment and more on delivering quality research outcomes, no matter where their studies are taking place.
For CROs, this simplicity is a major advantage. Teams no longer juggle multiple vendors, systems or integrations. Instead, they can centralise data capture, trial management and reporting with intuitive tools, role‑based access and real‑time visibility.
Flexibility that adapts to any trial
One of the strongest reasons for CROs choosing Xolomon is the platform’s adaptability. Whether it’s a single‑site observational study or a large, multi‑centre clinical trial with complex case report forms, Xolomon allows teams to:
- Customise eCRDs quickly and effectively
- Deploy ePROs for patient‑reported outcomes
- Integrate data across eCRD, CTMS and mobile apps
- Generate real‑time reports and dashboards
This flexibility means CROs can tailor their digital stack to each sponsor’s requirements without costly development work or long implementation cycles.
A unified digital ecosystem
Gone are the days when CROs had to stitch together separate software for enrolment tracking, budgeting, monitoring, reporting and compliance. Xolomon’s ecosystem connects these functions, giving CRO teams a holistic view of trial progress and data quality.
For example, a sponsor might use the same platform for eCRD (electronic Case Report Data) and ePRO (patient diaries and outcomes), while the CRO uses the CTMS (Clinical Trial Management System) to oversee timelines, budgets and milestones. Because these modules are built on the same technology foundation, data flows securely and consistently between them, avoiding redundancy and reducing administrative overhead.
Compliance and security you can trust
Regulatory compliance is a priority in clinical research, and CROs choosing Xolomon do so with confidence. The platform complies with key standards, including GDPR in Europe, the FDA’s 21 CFR Part 11 and EMA guidelines. It also incorporates secure data storage, traceability and audit trails, features that are essential for maintaining regulatory readiness and preparing for inspections.
This gives CROs peace of mind when sharing data with sponsors or preparing submissions, knowing that the information is consistent, traceable and stored securely.
Cost‑effective and supportive partnerships
Another key factor driving CROs choosing Xolomon is the way it supports different types of partnerships. From one‑off project collaborations to long‑term strategic agreements, Xolomon offers pricing plans and support structures that help CROs avoid hidden costs, such as maintaining in‑house systems, dealing with multiple vendors or handling continuous maintenance and upgrades.
The bottom line
Whether you are a global CRO managing thousands of patient records, or a smaller research organisation growing your digital footprint, Xolomon delivers a flexible, integrated and secure platform to power your digital trials.
If you’re a CRO seeking a partner that combines adaptability with regulatory compliance and real‑time insights, it’s no surprise that more and more organisations are choosing Xolomon.
Xolomon: making research accesible
